Clinical Trials Logo

Post-Essential Thrombocytopenia clinical trials

View clinical trials related to Post-Essential Thrombocytopenia.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00931762 Terminated - Clinical trials for Primary Myelofibrosis

A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis

Start date: August 31, 2009
Phase: Phase 2
Study type: Interventional

This study assessed the safety and efficacy of Panobinostat as a single agent in the treatment of Primary Myelofibrosis, Post-Polycythemia Vera and Post-Essential Thrombocythemia. There were two cohorts - participants with JAK2 mutation and participants without JAK2 mutation.